๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-07-16

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy (NCT06413706)

A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination With Temozolomide Compared to Temozolomide Monotherapy in Children and Young Adults With Newly Diagnosed High-Grade Glioma Following Radiotherapy

๐Ÿ”ต Active, Not Recruiting Phase2 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Eli Lilly and Company

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of this study is to measure the benefit of adding abemaciclib to the chemotherapy, temozolomide, for newly diagnosed high-grade glioma following radiotherapy. Your participation could last approximately 11 months and possibly longer depending upon how you and your tumor respond.

Who can join: Review the eligibility criteria below.

Location: Children's Hospital of Orange County - Orange โ€” Orange, California

Age range: 0 Years to 20 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (37 Sites)

Showing the first 25 of 37 sites.

  • Children's Hospital of Orange County - Orange โ€” Orange, California
  • Lucile Packard Children's Hospital (LPCH) - Stanford University โ€” Palo Alto, California
  • Riley Hospital for Children at Indiana University Health โ€” Indianapolis, Indiana
  • The Johns Hopkins Hospital (JHH) - Johns Hopkins Childrens Center โ€” Baltimore, Maryland
  • University of Michigan Health System (UMHS) - C.S. Mott Children's Hospital - Hematology Oncology Clinic โ€” Ann Arbor, Michigan
  • Mayo Clinic โ€” Rochester, Minnesota
  • Rhode Island Hospital โ€” Providence, Rhode Island
  • UT Southwestern Medical Center Dallas/Childrens Medical Center โ€” Dallas, Texas
  • The University of Texas MD Anderson Cancer Center โ€” Houston, Texas
  • Queensland Government- Lady Cilento Children's Hospital โ€” Brisbane,
  • Perth Children's Hospital โ€” Nedlands,
  • The Children's Hospital at Westmead โ€” Westmead,
  • Universitair Ziekenhuis Gent (Uz Gent) โ€” Ghent,
  • Universitair Ziekenhuis Leuven โ€” Leuven,
  • Universite Catholique de Louvain (UCL) - Cliniques Universitaires Saint-Luc โ€” Woluwe-Saint-Lambert,
  • Copenhagen University Hospital-Rigshospitalet University Hospital โ€” Copenhagen,
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants โ€” Bordeaux,
  • Centre de Lutte Contre le Cancer (CLCC) - Centre Oscar Lambret โ€” Lille,
  • Centre Leon Berard โ€” Lyon,
  • Hopital La Timone โ€” Marseille,
  • Institut Curie โ€” Paris,
  • Institut Gustave Roussy-Gustave Roussy Cancer Center -DITEP โ€” Villejuif,
  • Fondazione IRCCS Istituto Nazionale dei Tumori โ€” Milan,
  • Azienda Ospedaliera Di Rilievo Nazionale Santobono Pausilipon โ€” Naples,
  • IRCCS Ospedale Pediatrico Bambino Gesu โ€” Rome,

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Glioma clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—